US FDA approves Johnson & Johnson's blood cancer therapy 11/08/2023 (VOVWORLD) - Johnson & Johnson said on Thursday the US Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer